Company

BioGend Therapeutics Co. Ltd

Headquarters: Taipei City, Taiwan

TWSE: 6733 +0.64%

Market Cap

TW$4.47 Billion

TWD as of Jan. 1, 2025

US$136.1 Million

Market Cap History

BioGend Therapeutics Co. Ltd Categories

Taiwan Healthcare Biotechnology
Taiwan Healthcare Taiwan Biotechnology

BioGend Therapeutics Co. Ltd market capitalization over time

Evolution of BioGend Therapeutics Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of BioGend Therapeutics Co. Ltd

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $113.24 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $76.33 B
Marinomed Biotech AG $56.13 B
Sector:
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Detailed Description

BioGend Therapeutics Co., Ltd. develops regenerative bio-orthopaedic products. The company is developing BiG-001 and BiG-006, an osteoinductive bone graft substitute; and BiG-009, an autologous cartilage repair system. BioGend Therapeutics Co., Ltd. was founded in 2016 and is based in Taipei, Taiwan.

Stocks & Indices

BioGend Therapeutics Co. Ltd has the following listings and related stock indices.


Stock: TWSE: 6733 wb_incandescent

Details

Headquarters:

No.3-2, Park ST.

4th Floor Nangang District

Taipei City, 115

Taiwan

Phone: 886 2 2655 8366